Skip to main content
. 2017 Oct 10;8(55):94619–94634. doi: 10.18632/oncotarget.21816

Figure 5. LY2624587 antibody induced mobilization of WBCs, neutrophils, and HSCs in monkeys.

Figure 5

LY2624587 (CXCR4 mAb) induced changes in (A) total WBCs, (B) neutrophils, and (C) CD34+ HSCs, vs. positive control LY2510924 (peptide antagonist) acetate salt form (LSN2534820). (D) LY2624587 (CXCR4 mAb) plasma concentrations after 10- or 30-mg/kg single doses.